LASA SUPERGENERICS Financial Statement Analysis
|
||
|
The Revenues of LASA SUPERGENERICS have decreased by -19.47% YoY .
The Earnings Per Share (EPS) of LASA SUPERGENERICS has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
LASA SUPERGENERICS Last 5 Annual Financial Results
[BOM: 540702|NSE : LASA]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹104 Cr | ₹130 Cr | ₹137 Cr | ₹202 Cr | ₹167 Cr |
| Expenses | ₹102 Cr | ₹136 Cr | ₹121 Cr | ₹155 Cr | ₹137 Cr |
| Operating Profit (Excl OI) | ₹2.22 Cr | ₹-6.60 Cr | ₹16 Cr | ₹47 Cr | ₹30 Cr |
| Other Income | ₹0.10 Cr | ₹1.84 Cr | ₹0.28 Cr | ₹0.18 Cr | ₹0.23 Cr |
| Interest | ₹1.99 Cr | ₹4.19 Cr | ₹0.07 Cr | ₹2.07 Cr | ₹8.12 Cr |
| Depreciation | ₹11 Cr | ₹13 Cr | ₹15 Cr | ₹16 Cr | ₹17 Cr |
| Profit Before Tax | ₹-19 Cr | ₹-42 Cr | ₹-6.14 Cr | ₹29 Cr | ₹4.74 Cr |
| Profit After Tax | ₹-22 Cr | ₹-39 Cr | ₹-5.33 Cr | ₹23 Cr | ₹3.63 Cr |
| Earnings Per Share (Rs) | ₹-4.34 | ₹-7.71 | ₹-1.06 | ₹5.60 | ₹0.89 |
| PAT Margin (%) | -20.83 | -29.81 | -3.89 | 11.25 | 2.17 |
| ROE(%) | -20.22 | -27.97 | -3.37 | 15.17 | 2.94 |
| ROCE(%) | -13.23 | -23.94 | -3.41 | 17.14 | 6.77 |
| Total Debt/Equity(x) | 0.23 | 0.18 | 0.13 | 0.12 | 0.34 |
Key Financials |
||
| Market Cap | : | ₹ 127.9 Cr |
| Revenue (TTM) | : | ₹ 119.7 Cr |
| Net Profit(TTM) | : | ₹ -22.7 Cr |
| EPS (TTM) | : | ₹ -4.5 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| LASA SUPERGENERICS | -5.8% | -5.5% | -30.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -3.7% | -2.5% | 31.9% |
| CIPLA | -3.2% | 0% | 8.2% |
| DR REDDYS LABORATORIES | -2.4% | 7.3% | 15.3% |
| ZYDUS LIFESCIENCES | 2% | 2.3% | 37.9% |
| DIVIS LABORATORIES | 2.3% | 2.1% | 46.9% |
| MANKIND PHARMA | -7.1% | 1.2% | 20.5% |
| TORRENT PHARMACEUTICALS | -2.1% | -2.8% | 37.8% |
| LUPIN | -4.3% | 3.8% | 53.3% |
LASA SUPERGENERICS Revenues
[BOM: 540702|NSE : LASA]
| Y-o-Y | -19.47 % |
| 5 Yr CAGR | -11.13 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹104 Cr | -19.47 | |
| Mar2023 | ₹130 Cr | -5.51 | |
| Mar2022 | ₹137 Cr | -32.24 | |
| Mar2021 | ₹202 Cr | 21.00 | |
| Mar2020 | ₹167 Cr | - | |
LASA SUPERGENERICS Operating Profit
[BOM: 540702|NSE : LASA]
| Y-o-Y | Positive |
| 5 Yr CAGR | -47.81 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹2.22 Cr | Positive | |
| Mar2023 | ₹-6.60 Cr | Negative | |
| Mar2022 | ₹16 Cr | -66.07 | |
| Mar2021 | ₹47 Cr | 57.53 | |
| Mar2020 | ₹30 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | -41.28 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 2.13% | Positive | |
| Mar2023 | -5.09% | Negative | |
| Mar2022 | 11.68% | -49.91 | |
| Mar2021 | 23.32% | 30.13 | |
| Mar2020 | 17.92% | - | |
LASA SUPERGENERICS Profit After Tax
[BOM: 540702|NSE : LASA]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹-22 Cr | Negative | |
| Mar2023 | ₹-39 Cr | Negative | |
| Mar2022 | ₹-5.33 Cr | Negative | |
| Mar2021 | ₹23 Cr | 527.84 | |
| Mar2020 | ₹3.63 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | -20.83 % | Negative | |
| Mar2023 | -29.81 % | Negative | |
| Mar2022 | -3.89 % | Negative | |
| Mar2021 | 11.25 % | 418.43 | |
| Mar2020 | 2.17 % | - | |
LASA SUPERGENERICS Earnings Per Share (EPS)
[BOM: 540702|NSE : LASA]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹-4.34 | Negative | |
| Mar2023 | ₹-7.71 | Negative | |
| Mar2022 | ₹-1.06 | Negative | |
| Mar2021 | ₹5.60 | 529.21 | |
| Mar2020 | ₹0.89 | - | |
LASA SUPERGENERICS Return on Capital Employed (ROCE)
[BOM: 540702|NSE : LASA]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | -13.23% | Negative | |
| Mar2023 | -23.94% | Negative | |
| Mar2022 | -3.41% | Negative | |
| Mar2021 | 17.14% | 153.18 | |
| Mar2020 | 6.77% | - | |
LASA SUPERGENERICS Share Price vs Sensex
| Current Share Price | : | ₹25.5 |
| Current MarketCap | : | ₹ 127.9 Cr |
| Updated EOD on | : | Jan 14,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -5.8% |
-5.5% |
-30.2% |
| SENSEX | -2.2% |
-5.9% |
7.2% |
LASA SUPERGENERICS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about LASA SUPERGENERICS Financials
How the annual revenues of LASA SUPERGENERICS have changed ?
The Revenues of LASA SUPERGENERICS have decreased by -19.47% YoY .
How the Earnings per Share (EPS) of LASA SUPERGENERICS have changed?
The Earnings Per Share (EPS) of LASA SUPERGENERICS has decreased by Negative YoY .
Check out Intrinsic Value of Peers of LASA SUPERGENERICS
Compare Stock Analytics of Peers of LASA SUPERGENERICS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
